Cargando…

Metabolic reprogramming in colorectal cancer: regulatory networks and therapy

With high prevalence and mortality, together with metabolic reprogramming, colorectal cancer is a leading cause of cancer-related death. Metabolic reprogramming gives tumors the capacity for long-term cell proliferation, making it a distinguishing feature of cancer. Energy and intermediate metabolit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jieping, Zou, Shaomin, Fang, Lekun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906896/ https://www.ncbi.nlm.nih.gov/pubmed/36755301 http://dx.doi.org/10.1186/s13578-023-00977-w

Ejemplares similares

Dysbiosis of gut microbiota in promoting the development of colorectal cancer
por: Zou, Shaomin, et al.
Publicado: (2018)

3,3′-Diindolylmethane Enhances Fluorouracil Sensitivity via Inhibition of Pyrimidine Metabolism in Colorectal Cancer
por: Zhang, Jieping, et al.
Publicado: (2022)

Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy
por: Nenkov, Miljana, et al.
Publicado: (2021)

BAF53A drives colorectal cancer development by regulating DUSP5-mediated ERK phosphorylation
por: Yang, Ziqing, et al.
Publicado: (2022)

The Regulatory Network of MicroRNA in the Metabolism of Colorectal Cancer
por: Li, Wangji, et al.
Publicado: (2021)

ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis
por: Yang, Ziqing, et al.
Publicado: (2023)

Reprogrammed Lipid Metabolism and the Lipid-Associated Hallmarks of Colorectal Cancer
por: Salita, Timothy, et al.
Publicado: (2022)

Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
por: Sasidharan Nair, Varun, et al.
Publicado: (2021)

Reprogramming of macrophages employing gene regulatory and metabolic network models
por: Hörhold, Franziska, et al.
Publicado: (2020)

MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers
por: Pinweha, Pannapa, et al.
Publicado: (2016)

Rho GDP‐dissociation inhibitor α is a potential prognostic biomarker and controls telomere regulation in colorectal cancer
por: Huang, Dandan, et al.
Publicado: (2017)

Metabolic Reprogramming and Its Regulatory Mechanism in Sepsis-Mediated Inflammation
por: Liu, Wenzhang, et al.
Publicado: (2023)

Metabolic Reprogramming: A Friend or Foe to Cancer Therapy?
por: McCann, Christopher, et al.
Publicado: (2021)

Metabolic Controls on Epigenetic Reprogramming in Regulatory T Cells
por: Lu, Jingli, et al.
Publicado: (2021)

DEHP mediates drug resistance by metabolic reprogramming in colorectal cancer cells
por: Wu, Yue, et al.
Publicado: (2023)

Biomarkers of coordinate metabolic reprogramming and the construction of a co-expression network in colorectal cancer
por: Lin, Lihong, et al.
Publicado: (2022)

Targeting Mitochondrial Metabolic Reprogramming as a Potential Approach for Cancer Therapy
por: Zhang, Liufeng, et al.
Publicado: (2023)

Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer
por: Deris Zayeri, Zeinab, et al.
Publicado: (2023)

Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis
por: Yang, Yi-Fang, et al.
Publicado: (2022)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
por: Nong, Shiqi, et al.
Publicado: (2023)

Elucidating the Reprograming of Colorectal Cancer Metabolism Using Genome-Scale Metabolic Modeling
por: Zhang, Cheng, et al.
Publicado: (2019)

Interferons: Reprogramming the Metabolic Network against Viral Infection
por: Raniga, Kavita, et al.
Publicado: (2018)

Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming
por: Li, Zhenzhen, et al.
Publicado: (2021)

Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer
por: Shum, Hang Chee Erin, et al.
Publicado: (2023)

Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer
por: Chetta, Paolo, et al.
Publicado: (2021)

Metabolic reprogramming in prostate cancer
por: Ahmad, Fahim, et al.
Publicado: (2021)

METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
por: Wei, Wei, et al.
Publicado: (2023)

Lactate-related metabolic reprogramming and immune regulation in colorectal cancer
por: Sun, Qianhui, et al.
Publicado: (2023)

Multi-omics analyses of glucose metabolic reprogramming in colorectal cancer
por: Huang, Maosen, et al.
Publicado: (2023)

Targeting HIBCH to reprogram valine metabolism for the treatment of colorectal cancer
por: Shan, Yunlong, et al.
Publicado: (2019)

Metabolic reprogramming and epigenetic modifications on the path to cancer
por: Sun, Linchong, et al.
Publicado: (2021)

The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs
por: Puckett, Dexter L., et al.
Publicado: (2021)

The Role of Reprogrammed Glucose Metabolism in Cancer
por: Ediriweera, Meran Keshawa, et al.
Publicado: (2023)

Lipid metabolic reprogramming in cancer cells
por: Beloribi-Djefaflia, S, et al.
Publicado: (2016)

The cancer metabolic reprogramming and immune response
por: Xia, Longzheng, et al.
Publicado: (2021)

Evolutionary Origins of Metabolic Reprogramming in Cancer
por: García-Sancha, Natalia, et al.
Publicado: (2022)

Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
por: Yan, Liang, et al.
Publicado: (2021)

Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
por: Sreedhar, Annapoorna, et al.
Publicado: (2018)

Immune cell metabolism and metabolic reprogramming
por: Hu, Chenchen, et al.
Publicado: (2022)

Gene regulatory network reconfiguration in direct lineage reprogramming
por: Kamimoto, Kenji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cb04uug4b9b9v096bo1alfcpmq